Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS)
CNY 9.33
(0.0%)
CNY 9.33
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 290.34 Million CNY | -1.7% |
| 2022 | 295.36 Million CNY | -12.64% |
| 2021 | 338.09 Million CNY | -3.18% |
| 2020 | 349.17 Million CNY | -11.29% |
| 2019 | 393.6 Million CNY | -1.35% |
| 2018 | 398.99 Million CNY | 12.65% |
| 2017 | 354.17 Million CNY | 47.57% |
| 2016 | 240 Million CNY | 10.29% |
| 2015 | 217.62 Million CNY | 8.6% |
| 2014 | 200.39 Million CNY | -12.87% |
| 2013 | 230 Million CNY | 13.21% |
| 2012 | 203.16 Million CNY | 16.09% |
| 2011 | 174.99 Million CNY | 5.64% |
| 2010 | 165.65 Million CNY | 17.88% |
| 2009 | 140.53 Million CNY | 9.12% |
| 2008 | 128.78 Million CNY | -1.81% |
| 2007 | 131.16 Million CNY | 13.03% |
| 2006 | 116.03 Million CNY | -12.97% |
| 2005 | 133.32 Million CNY | 26.38% |
| 2004 | 105.49 Million CNY | 1.56% |
| 2003 | 103.87 Million CNY | -13.67% |
| 2002 | 120.32 Million CNY | -23.42% |
| 2001 | 157.11 Million CNY | 1.63% |
| 2000 | 154.59 Million CNY | 61.58% |
| 1999 | 95.67 Million CNY | 9.59% |
| 1998 | 87.3 Million CNY | 23.94% |
| 1997 | 70.43 Million CNY | 21.83% |
| 1996 | 57.81 Million CNY | -35.04% |
| 1995 | 89 Million CNY | -53.67% |
| 1994 | 192.12 Million CNY | 610.98% |
| 1993 | 27.02 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 309.84 Million CNY | 6.11% |
| 2024 Q2 | 292.01 Million CNY | 9.44% |
| 2024 Q1 | 266.82 Million CNY | -8.1% |
| 2023 Q4 | 290.34 Million CNY | -19.97% |
| 2023 Q1 | 289.7 Million CNY | -1.92% |
| 2023 Q2 | 275.76 Million CNY | -4.81% |
| 2023 FY | 290.34 Million CNY | -1.7% |
| 2023 Q3 | 362.8 Million CNY | 31.56% |
| 2022 Q4 | 295.36 Million CNY | -7.1% |
| 2022 FY | 295.36 Million CNY | -12.64% |
| 2022 Q1 | 333.42 Million CNY | -1.38% |
| 2022 Q2 | 332.32 Million CNY | -0.33% |
| 2022 Q3 | 317.91 Million CNY | -4.34% |
| 2021 Q4 | 338.09 Million CNY | -1.13% |
| 2021 Q1 | 350.81 Million CNY | 0.47% |
| 2021 FY | 338.09 Million CNY | -3.18% |
| 2021 Q2 | 344.9 Million CNY | -1.68% |
| 2021 Q3 | 341.95 Million CNY | -0.86% |
| 2020 FY | 349.17 Million CNY | -11.29% |
| 2020 Q1 | 384.78 Million CNY | -2.24% |
| 2020 Q2 | 386.76 Million CNY | 0.52% |
| 2020 Q3 | 382.3 Million CNY | -1.15% |
| 2020 Q4 | 349.17 Million CNY | -8.67% |
| 2019 Q1 | 390.58 Million CNY | -2.11% |
| 2019 Q4 | 393.6 Million CNY | -9.73% |
| 2019 FY | 393.6 Million CNY | -1.35% |
| 2019 Q3 | 436.02 Million CNY | 1.12% |
| 2019 Q2 | 431.2 Million CNY | 10.4% |
| 2018 Q2 | 340.86 Million CNY | -16.13% |
| 2018 Q1 | 406.44 Million CNY | 14.76% |
| 2018 Q4 | 398.99 Million CNY | 13.32% |
| 2018 FY | 398.99 Million CNY | 12.65% |
| 2018 Q3 | 352.09 Million CNY | 3.29% |
| 2017 Q2 | 234.73 Million CNY | 6.15% |
| 2017 Q4 | 354.17 Million CNY | 42.5% |
| 2017 FY | 354.17 Million CNY | 47.57% |
| 2017 Q1 | 221.13 Million CNY | -7.86% |
| 2017 Q3 | 248.55 Million CNY | 5.89% |
| 2016 Q1 | 244.16 Million CNY | 12.2% |
| 2016 Q2 | 231.76 Million CNY | -5.08% |
| 2016 Q4 | 240 Million CNY | 2.08% |
| 2016 Q3 | 235.11 Million CNY | 1.45% |
| 2016 FY | 240 Million CNY | 10.29% |
| 2015 FY | 217.62 Million CNY | 8.6% |
| 2015 Q2 | 189.9 Million CNY | -1.33% |
| 2015 Q3 | 195.16 Million CNY | 2.77% |
| 2015 Q4 | 217.62 Million CNY | 11.51% |
| 2015 Q1 | 192.46 Million CNY | -3.96% |
| 2014 Q1 | 206 Million CNY | -10.44% |
| 2014 Q2 | 240.14 Million CNY | 16.58% |
| 2014 Q3 | 201.94 Million CNY | -15.91% |
| 2014 FY | 200.39 Million CNY | -12.87% |
| 2014 Q4 | 200.39 Million CNY | -0.77% |
| 2013 Q3 | 232.15 Million CNY | 2.21% |
| 2013 Q4 | 230 Million CNY | -0.93% |
| 2013 FY | 230 Million CNY | 13.21% |
| 2013 Q1 | 213.37 Million CNY | 5.03% |
| 2013 Q2 | 227.13 Million CNY | 6.45% |
| 2012 FY | 203.16 Million CNY | 16.09% |
| 2012 Q1 | 158.73 Million CNY | -9.29% |
| 2012 Q4 | 203.16 Million CNY | 11.87% |
| 2012 Q2 | 173.67 Million CNY | 9.41% |
| 2012 Q3 | 181.6 Million CNY | 4.56% |
| 2011 FY | 174.99 Million CNY | 5.64% |
| 2011 Q3 | 142.66 Million CNY | -8.58% |
| 2011 Q2 | 156.04 Million CNY | -5.5% |
| 2011 Q4 | 174.99 Million CNY | 22.67% |
| 2011 Q1 | 165.12 Million CNY | -0.32% |
| 2010 FY | 165.65 Million CNY | 17.88% |
| 2010 Q2 | 124.33 Million CNY | 1.26% |
| 2010 Q3 | 119.81 Million CNY | -3.63% |
| 2010 Q4 | 165.65 Million CNY | 38.26% |
| 2010 Q1 | 122.78 Million CNY | -12.63% |
| 2009 Q2 | 114.83 Million CNY | -3.97% |
| 2009 Q3 | 111.48 Million CNY | -2.92% |
| 2009 Q4 | 140.53 Million CNY | 26.05% |
| 2009 FY | 140.53 Million CNY | 9.12% |
| 2009 Q1 | 119.58 Million CNY | -7.14% |
| 2008 Q3 | 135.3 Million CNY | -2.25% |
| 2008 Q1 | 151.42 Million CNY | 15.45% |
| 2008 Q4 | 128.78 Million CNY | -4.82% |
| 2008 FY | 128.78 Million CNY | -1.81% |
| 2008 Q2 | 138.41 Million CNY | -8.59% |
| 2007 Q4 | 131.16 Million CNY | -20.61% |
| 2007 Q3 | 165.21 Million CNY | 40.44% |
| 2007 FY | 131.16 Million CNY | 13.03% |
| 2007 Q2 | 117.64 Million CNY | -20.03% |
| 2007 Q1 | 147.1 Million CNY | 26.78% |
| 2006 Q3 | 130.13 Million CNY | 8.07% |
| 2006 Q1 | 124.95 Million CNY | -6.28% |
| 2006 Q4 | 116.03 Million CNY | -10.83% |
| 2006 FY | 116.03 Million CNY | -12.97% |
| 2006 Q2 | 120.41 Million CNY | -3.63% |
| 2005 Q4 | 133.32 Million CNY | 16.93% |
| 2005 FY | 133.32 Million CNY | 26.38% |
| 2005 Q3 | 114.01 Million CNY | -0.18% |
| 2005 Q2 | 114.22 Million CNY | -1.38% |
| 2005 Q1 | 115.82 Million CNY | 9.79% |
| 2004 Q1 | 117.46 Million CNY | 13.08% |
| 2004 Q2 | 110.03 Million CNY | -6.32% |
| 2004 Q3 | 99.88 Million CNY | -9.23% |
| 2004 FY | 105.49 Million CNY | 1.56% |
| 2004 Q4 | 105.49 Million CNY | 5.62% |
| 2003 Q4 | 103.87 Million CNY | 1.72% |
| 2003 Q1 | 133.78 Million CNY | 11.19% |
| 2003 Q3 | 102.12 Million CNY | -13.96% |
| 2003 Q2 | 118.69 Million CNY | -11.28% |
| 2003 FY | 103.87 Million CNY | -13.67% |
| 2002 FY | 120.32 Million CNY | -23.42% |
| 2002 Q3 | 122.11 Million CNY | -26.44% |
| 2002 Q2 | 166.01 Million CNY | 4.43% |
| 2002 Q1 | 158.97 Million CNY | 1.18% |
| 2002 Q4 | 120.32 Million CNY | -1.47% |
| 2001 Q4 | 157.11 Million CNY | 0.0% |
| 2001 Q2 | 120.99 Million CNY | 0.0% |
| 2001 FY | 157.11 Million CNY | 1.63% |
| 2000 Q4 | 154.59 Million CNY | 0.0% |
| 2000 FY | 154.59 Million CNY | 61.58% |
| 2000 Q2 | 156.6 Million CNY | 0.0% |
| 1999 FY | 95.67 Million CNY | 9.59% |
| 1999 Q2 | 93.08 Million CNY | 0.0% |
| 1999 Q4 | 95.67 Million CNY | 0.0% |
| 1998 FY | 87.3 Million CNY | 23.94% |
| 1998 Q4 | 87.3 Million CNY | 0.0% |
| 1998 Q2 | 86.39 Million CNY | 0.0% |
| 1997 Q4 | 70.43 Million CNY | 0.0% |
| 1997 Q2 | 51.36 Million CNY | 0.0% |
| 1997 FY | 70.43 Million CNY | 21.83% |
| 1996 FY | 57.81 Million CNY | -35.04% |
| 1996 Q4 | 57.81 Million CNY | 0.0% |
| 1996 Q2 | 105.24 Million CNY | 0.0% |
| 1995 FY | 89 Million CNY | -53.67% |
| 1995 Q4 | 89 Million CNY | 0.0% |
| 1995 Q2 | 45.18 Million CNY | 0.0% |
| 1994 FY | 192.12 Million CNY | 610.98% |
| 1994 Q2 | 21.61 Million CNY | 0.0% |
| 1994 Q4 | 192.12 Million CNY | 0.0% |
| 1993 FY | 27.02 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.75 Billion CNY | 89.448% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | 90.76% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | 92.534% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 887.5 Million CNY | 67.286% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | 73.601% |
| NanJing Pharmaceutical Company Limited | 20.95 Billion CNY | 98.615% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.12 Billion CNY | 74.089% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 527.57 Million CNY | 44.967% |